This event will highlight and discuss recent advances in strategies for controlling stem cell fate and reprogramming (including new insights into the molecular basis of pluripotency and differentiation) together with the progress towards therapeutic and bioprocessing.
This event has CPD accreditation
This event has an open abstract session. Abstracts can be submitted on any subject related to Stem Cells
The Deadline for abstract submissions for oral presentation is March 10th 2015
Abstracts for poster presentation only can be submitted up to two weeks before the event
.You can download the instructions for authors at www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
Who Should Attend
Anyone with an interest in stem cell biology, differentiation and use in biomedicine should attend this event, including, but not exclusively people from:
Biotech and Pharma Industry: CEOs, Chief Scientists, Group Heads, Senior and Junior Scientists, Research Managers
Academic and Research Institutes: Group and Lab Heads, Postdoctoral Scientists and Research Students
Talks include
MicroRNA Activity and Adult Stem Cell Differentiation: Utilising the Epigenome
Assistant Professor Christopher J. Payne, PhD, Human Molecular Genetics Program, Ann & Robert H. Lurie Children's Hospital of Chicago Research Center, Departments of Pediatrics and Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
TBC
Dr. PV. Mohanan, PhD, FST, FASc(Aw), FSAB, Scientist & Head, Toxicology Division, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology (Govt. of India), Poojapura, Thiruvananthapuram, Kerala, India
Direct Conversion of Pluripotent Human Embryonic Stem Cells into Functional Human Neuronal or Cardiomyocyte Cell Therapy Derivatives for Regenerative Medicine
Dr. Xuejun H Parsons, San Diego Regenerative Medicine Institute & Xcelthera Inc, San Diego, CA, United States
Synthetic mRNAs as optimised tools for stem cell generation and for manipulating cellular phenotypes
Dr. Guido Krupp, CEO and President, AmpTec GmbH, Koenigstr. 4A D-22767 Hamburg, Germany
Decellularized organs: Whole organ construction with stem cells
Dr Karthikeyan Narayanan, Senior Research Scientist, Institute of Bioengineering and Nanotechnology, NANOS, Biopolis, Singapore
The identification of novel factors involved in migration of stem cells to site of injury
Dr Adiba Isa, Postdoc, Dr.Med.Sci., Laboratory of Molecular Endocrinology (KMEB), Institute of Clinical Research, University of Southern Denmark, Odense C, Denmark
TBC
Dr Gabor FoldesGabor Foldes, MD PhD, National Heart and Lung Institute, Imperial College London, Imperial Centre for Experimental and Translational Medicine, Hammersmith Campus, London, UK
TBC
Dr Patrizia Ferretti, Stem Cells and Regenerative Medicine Section, UCL Institute of Child Health, London, UK
TBC
Dr Marianne Ellis, RAEng/The Leverhulme Trust Senior Research Fellow, Senior Lecturer, Department of Chemical Engineering, University of Bath, Bath, UK
This event has CPD accreditation
This event has an open abstract session. Abstracts can be submitted on any subject related to Stem Cells
The Deadline for abstract submissions for oral presentation is March 10th 2015
Abstracts for poster presentation only can be submitted up to two weeks before the event
.You can download the instructions for authors at www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
Who Should Attend
Anyone with an interest in stem cell biology, differentiation and use in biomedicine should attend this event, including, but not exclusively people from:
Biotech and Pharma Industry: CEOs, Chief Scientists, Group Heads, Senior and Junior Scientists, Research Managers
Academic and Research Institutes: Group and Lab Heads, Postdoctoral Scientists and Research Students
Talks include
MicroRNA Activity and Adult Stem Cell Differentiation: Utilising the Epigenome
Assistant Professor Christopher J. Payne, PhD, Human Molecular Genetics Program, Ann & Robert H. Lurie Children's Hospital of Chicago Research Center, Departments of Pediatrics and Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
TBC
Dr. PV. Mohanan, PhD, FST, FASc(Aw), FSAB, Scientist & Head, Toxicology Division, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology (Govt. of India), Poojapura, Thiruvananthapuram, Kerala, India
Direct Conversion of Pluripotent Human Embryonic Stem Cells into Functional Human Neuronal or Cardiomyocyte Cell Therapy Derivatives for Regenerative Medicine
Dr. Xuejun H Parsons, San Diego Regenerative Medicine Institute & Xcelthera Inc, San Diego, CA, United States
Synthetic mRNAs as optimised tools for stem cell generation and for manipulating cellular phenotypes
Dr. Guido Krupp, CEO and President, AmpTec GmbH, Koenigstr. 4A D-22767 Hamburg, Germany
Decellularized organs: Whole organ construction with stem cells
Dr Karthikeyan Narayanan, Senior Research Scientist, Institute of Bioengineering and Nanotechnology, NANOS, Biopolis, Singapore
The identification of novel factors involved in migration of stem cells to site of injury
Dr Adiba Isa, Postdoc, Dr.Med.Sci., Laboratory of Molecular Endocrinology (KMEB), Institute of Clinical Research, University of Southern Denmark, Odense C, Denmark
TBC
Dr Gabor FoldesGabor Foldes, MD PhD, National Heart and Lung Institute, Imperial College London, Imperial Centre for Experimental and Translational Medicine, Hammersmith Campus, London, UK
TBC
Dr Patrizia Ferretti, Stem Cells and Regenerative Medicine Section, UCL Institute of Child Health, London, UK
TBC
Dr Marianne Ellis, RAEng/The Leverhulme Trust Senior Research Fellow, Senior Lecturer, Department of Chemical Engineering, University of Bath, Bath, UK
